Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
124.79%
↑ 1133% above average
Average (34q)
10.12%
Historical baseline
Range
High:124.79%
Low:-76.38%
Volatility
1987.4%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 124.79% |
| Q2 2025 | 80.00% |
| Q1 2025 | -76.38% |
| Q4 2024 | 68.82% |
| Q3 2024 | -10.00% |
| Q2 2024 | 28.57% |
| Q1 2024 | -44.48% |
| Q4 2023 | -9.74% |
| Q3 2023 | 36.93% |
| Q2 2023 | -16.67% |
| Q1 2023 | -26.18% |
| Q4 2022 | 40.56% |
| Q3 2022 | 15.79% |
| Q2 2022 | 24.00% |
| Q1 2022 | 40.48% |
| Q4 2021 | -7.69% |
| Q3 2021 | 4.88% |
| Q2 2021 | -36.67% |
| Q1 2021 | 26.83% |
| Q4 2020 | -17.14% |
| Q3 2020 | 44.44% |
| Q2 2020 | 29.21% |
| Q1 2020 | 27.64% |
| Q4 2019 | -0.82% |
| Q3 2019 | 4.69% |
| Q2 2019 | -19.63% |
| Q1 2019 | -9.18% |
| Q4 2018 | 45.86% |
| Q3 2018 | 41.04% |
| Q2 2018 | 44.08% |
| Q1 2018 | -23.93% |
| Q4 2017 | -19.09% |
| Q3 2017 | -43.63% |
| Q2 2017 | -13.10% |
| Q1 2017 | 0.00% |